Parkwood LLC Vaxcyte, Inc. Transaction History
Parkwood LLC
- $1.11 Billion
- Q1 2024
A detailed history of Parkwood LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Parkwood LLC holds 13,555 shares of PCVX stock, worth $1.05 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
13,555
Previous 15,480
12.44%
Holding current value
$1.05 Million
Previous $972,000
4.73%
% of portfolio
0.08%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding PCVX
# of Institutions
268Shares Held
97.1MCall Options Held
202KPut Options Held
147K-
Vanguard Group Inc Valley Forge, PA9.74MShares$757 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.51MShares$740 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.67MShares$597 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA4.92MShares$383 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.14MShares$322 Million0.07% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.61B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...